The device, used in treatment, was not returned for evaluation and the reported event could not be confirmed.Our clinical/medical team confirmed that based on the limited information provided, the root cause of the patient¿s reported pain, elevated cocr levels and altr which necessitated a revision cannot be concluded but the contraindicated use of competitor devices with the smith & nephew r3 devices cannot be ruled out.It cannot be concluded that the reported reactions/events were associated with a mal-performance of the s&n implant.The patient impact beyond the revision and expected post-operative healing/pain cannot be determined.No further clinical assessment is warranted at this time.A review of complaint history on the listed parts revealed no prior complaints for the listed batches with the same failure mode.A review of the manufacturing records did not reveal a manufacturing abnormality that could have caused or contributed to the reported incident.At this time, we have no reason to suspect that the product failed to meet any product specifications at the time of manufacture.A review of the risk management file and instructions for use document for this failure mode was conducted.Factors and/or potential probable causes that could have contributed to the reported event include but are not limited to contamination, patient condition/reaction, and a post-operative healing issue.Based on this investigation, the need for corrective action is not indicated.Without the actual product involved and/or device information, our investigation cannot proceed.If the device or new information is received in the future, this complaint can be re-opened.No further actions are being taken at this time.We consider this investigation closed.Be re-opened.We consider this investigation closed.
|